Blog | Life Sciences

Key takeaways from conversations with experts in life sciences on decentralized clinical trials, including technology, technical challenges, and the future.

Plain language summaries of clinical trial results are a critical tool for communicating research information to general audiences. Learn about key requirements.

How pharmaceutical organizations and CROs can connect and engage with diverse patients to increase inclusivity in clinical trials

Protecting IP for life sciences start-ups is a must, as IP is one of the most valuable assets. Consider these four key IP protection strategies for start-ups.

Using call center services can help sponsors recruit more diverse patient populations for clinical trials and maximize the impact of patient engagement and retention.

In the post-pandemic climate, there has been a sort of “forced evolution” for marketers within the life sciences sector. There is renewed focus on being able to effectively reach various audience segments, whether it is potential patient populations, HCPs, caregivers, or payers. The overall goal should move to being able to gain a much stronger level of engagement and get to a segment of one.

One of the latest initiatives being spearheaded by EMA is publishing ePI, or electronic product information. In some respects, the pharma industry has lagged behind other major industries in terms of how documentation and critical information is relayed to the end patient. Due to regulations, pharma still heavily relies on traditional Microsoft Word-based documentation for labeling that is managed with track changes and then ultimately printed. Besides not leveraging the latest technologies for patient benefit, the current process makes for a cumbersome translation process to provide the PI in the required 25 languages. The introduction of ePI will facilitate more effective and faster change management, version control, translation, and use of advanced translation tools. 

Centralizing global content for the migration of clinical outcome assessments to electronic format can streamline and simplify patient data reporting.

With rapidly evolving guidelines, it can be tricky to keep up with Medicare marketing requirements and ensure your marketing is resonating with your multilingual members.

Pharma digital marketing: check out some of the ways omnichannel and below-the-line marketing can improve customer experience and engagement.

A key concern for pharma companies is keeping a close eye on publications that might mention their product and its potential impact on the public. These publications can be extremely dense in volume, commanding careful review of multiple documents across several different sources. This review often needs to take place in a relatively short timeline and with strict reporting requirements.

Rethink product development using patient engagement strategies to help improve patients’ health and well-being. Read about challenges and opportunities.